Lund, Sweden, 18:30 CET, 18 July 2018 - BONESUPPORTTM, an emerging leader in orthobiologics for the management of bone voids, announces that Michael Diefenbeck MD PhD, BONESUPPORT`s Chief Medical Officer, has been appointed to assume a broader role as Head of R&D, Medical and Clinical Affairs. Emil Billbäck, CEO of BONESUPPORT, commented: `We are pleased to announce the expansion of Michael`s role to head of R&D, Medical and Clinical Affairs, where his experience at BONESUPPORT, both as Chief Medical Office and prior to this as an independent clinical advisor, as well as his clinical experience as an orthopedic surgeon specializing in trauma care and...
|
